REGULATION OF MYELINATION
REGULATION OF MYELINATION
批准号:
2263895
负责人:
JOSEPH F PODUSLO
金额:
$17.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-04-01 至 1995-03-31
关键词:
Schwann cells adenosine monophosphate axon carbohydrate biosynthesis connective tissue denervation developmental neurobiology fluorimetry forskolin gangliosides gene induction /repression genetic transcription genetic translation intracellular transport laboratory rat lysosomes messenger RNA myelin myelin basic proteins myelin proteolipid myelination myelinopathy nervous system regeneration northern blottings peripheral nervous system phosphodiesterases posttranslational modifications protein degradation radiotracer sciatic nerve second messengers wallerian degeneration
中文摘要
髓鞘基因表达的调控机制
周围神经系统在很大程度上是未知的。 进一步理解
转录、翻译和翻译后调节
髓磷脂基因的表达将为推进我们的研究提供重要信息。
了解人类疾病,其中脱髓鞘是突出的,因为
例如脱髓鞘性周围神经病变。 暗恋的典范
损伤和永久性切断成年大鼠坐骨神经(经典
Wallerian变性)已被证明是评估
髓鞘基因表达的调控。 这些实验动物模型
神经病变的特点是存在和缺乏轴突
再生和随后的髓鞘组装。 过去的努力得到了
该基金主要用于外周神经的主要糖蛋白PO
髓磷脂,其中转录、翻译和翻译后
PO表达的调节已被证实。 我现在提出一个
概念上新的研究方向,解决机制,
髓鞘基因的诱导和轴突在这种诱导中的作用,
正常的,被压碎的,永久性切断的神经 导频数据
显示毛喉素治疗神经内膜段
结果表明,大鼠坐骨神经损伤后,正常坐骨神经组织cAMP和PO mRNA水平升高,
和压碎的神经,但不是在永久性切断的神经。 这些
结果提供了一个工作假设,即轴突的存在是
所需的观察到的cAMP和PO mRNA水平的增加,并建议
cAMP的增加发生在轴突内,然后激活了一个
不同的雪旺细胞第二信使途径诱导PO基因
表情 提出实验来检验这一假设。 此外
为了进一步描述PO监管的特征,我现在计划将其扩展到
分析以评估其他髓磷脂基因的调节及其
产品,包括MBP,P2,MAG和CNE(以及神经节苷脂),
这两个模型作为两种损伤后时间的函数,
正常成人神经和发育中的神经。 这些实验将
解决其他髓鞘相关基因及其产物是否受到调控
以相似或不同的方式。 由于这一观察所支持的
假设PO在溶酶体中被永久降解后,
横断损伤,其他髓鞘
将评估神经横切后蛋白质的分解代谢。
了解这些不同的分解代谢途径将有助于破译
在各种脱髓鞘人类中观察到的脱髓鞘机制
神经病
英文摘要
The regulatory mechanisms that control myelin gene expression in the
peripheral nervous system are largely unknown. Further understanding of
the transcriptional, translational, and posttranslational regulation of
myelin gene expression will provide important information for advancing our
understanding of human disease where demyelination is prominent as in, for
example, the demyelinating peripheral neuropathies. The paradigms of crush
injury and permanent transection of the adult rat sciatic nerve (classical
Wallerian degeneration) have proven to be excellent models for evaluating
the regulation of myelin gene expression. These experimental animal models
of neuropathy are characterized by the presence and absence of axonal
regeneration and subsequent myelin assembly. Past efforts supported by
this grant have focused on PO, the major glycoprotein of peripheral nerve
myelin, where transcriptional, translational, and posttranslational
regulation of PO expression has been demonstrated. I now propose a
conceptionally new direction of research which addresses the mechanism of
myelin gene induction and the role that the axon plays in this induction in
the normal, crushed, and permanently transected nerve. Pilot data are
presented which demonstrate the forskolin treatment of endoneurial segments
of rat sciatic nerve results in increased cAMP and PO mRNA levels in normal
and crushed nerves, but not in the permanently transected nerves. These
results provide a working hypothesis that the presence of the axon is
required for the observed increase of cAMP and PO mRNA levels and suggest
that the cAMP increase occurs within the axon which then activates a
different Schwann cell second messenger pathway to induce PO gene
expression. Experiments are proposed to test this hypothesis. In addition
to the further characterization of PO regulation, I now plan to extend this
analysis to evaluate the regulation of other myelin genes and their
products, including MBP, P2, MAG, and CNPase (as well as gangliosides) in
these two models as a function of time after both injuries compared to the
normal adult nerve and the nerve during development. Such experiments will
address whether other myelin related genes and their products are regulated
in similar or different ways. Because of the observation supported by this
grant that PO is posttranslationally degraded in lysosomes after permanent
transection injury, the pathways and mechanisms by which other myelin
proteins are catabolized after nerve transection will be evaluated.
Understanding these different catabolic pathways will aid in deciphering
the mechanisms of demyelination as observed in various demyelinating human
neuropathies.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Regulation of myelination: axons not required for the biosynthesis of basal levels of the major myelin glycoprotein by Schwann cells in denervated distal segments of the adult cat sciatic nerve.
髓鞘形成的调节:成年猫坐骨神经去神经末节中的雪旺细胞生物合成基础水平的主要髓磷脂糖蛋白不需要轴突。
DOI:
10.1002/jnr.490140203
发表时间:
1985
期刊:
Journal of neuroscience research
影响因子:
4.2
作者:
[Poduslo,JF, Berg,CT, Ross,SM, Spencer,PS]
通讯作者:
Spencer,PS
Myelin-associated glycoprotein gene expression in the presence and absence of Schwann cell-axonal contact.
存在和不存在雪旺细胞轴突接触时髓磷脂相关糖蛋白基因的表达。
DOI:
10.1159/000111832
发表时间:
1990
期刊:
Developmental neuroscience
影响因子:
2.9
作者:
[Gupta,SK, Poduslo,JF, Dunn,R, Roder,J, Mezei,C]
通讯作者:
Mezei,C
Regulation of 2',3'-cyclic nucleotide phosphodiesterase gene expression in experimental peripheral neuropathies.
实验性周围神经病中 2,3-环核苷酸磷酸二酯酶基因表达的调节。
DOI:
10.1016/0169-328x(92)90149-6
发表时间:
1992
期刊:
Brain research. Molecular brain research
影响因子:
--
作者:
[LeBlanc,AC, Pringle,J, Lemieux,J, Poduslo,JF, Mezei,C]
通讯作者:
Mezei,C
A phorbol ester-sensitive kinase catalyzes the phosphorylation of P0 glycoprotein in myelin.
佛波酯敏感激酶催化髓磷脂中 P0 糖蛋白的磷酸化。
DOI:
10.1111/j.1471-4159.1987.tb02448.x
发表时间:
1987
期刊:
Journal of neurochemistry
影响因子:
4.7
作者:
[Brunden,KR, Poduslo,JF]
通讯作者:
Poduslo,JF
Isolation of an integral membrane glycoprotein by chloroform-methanol extraction and C3-reversed-phase high-performance liquid chromatography.
通过氯仿-甲醇萃取和 C3 反相高效液相色谱分离完整膜糖蛋白。
DOI:
10.1016/0003-2697(87)90521-5
发表时间:
1987
期刊:
Analytical biochemistry
影响因子:
2.9
作者:
[Brunden,KR, Berg,CT, Poduslo,JF]
通讯作者:
Poduslo,JF
共 10 条
Magnetic Resonance Imaging of Alzheimer's Amyloid Plaque
-
批准号:7069982
-
项目类别:
-
资助金额:$57.44万
-
财政年份:2003
-
负责人:JOSEPH F PODUSLO
-
依托单位:
Magnetic Resonance Imaging of Alzheimer's Amyloid Plaque
-
批准号:6893390
-
项目类别:
-
资助金额:$57.68万
-
财政年份:2003
-
负责人:JOSEPH F PODUSLO
-
依托单位:
Magnetic Resonance Imaging of Alzheimer's Amyloid Plaque
-
批准号:6752087
-
项目类别:
-
资助金额:$56.57万
-
财政年份:2003
-
负责人:JOSEPH F PODUSLO
-
依托单位:
Magnetic Resonance Imaging of Alzheimer's Amyloid Plaque
-
批准号:7236174
-
项目类别:
-
资助金额:$56.9万
-
财政年份:2003
-
负责人:JOSEPH F PODUSLO
-
依托单位:
Magnetic Resonance Imaging of Alzheimer's Amyloid Plaque
-
批准号:6599542
-
项目类别:
-
资助金额:$55.36万
-
财政年份:2003
-
负责人:JOSEPH F PODUSLO
-
依托单位:
THERAPEUTIC BENEFIT OF HYDROGEN PEROXIDE REMOVAL IN FALS
-
批准号:6261417
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2000
-
负责人:JOSEPH F PODUSLO
-
依托单位:
THERAPEUTIC BENEFIT OF HYDROGEN PEROXIDE REMOVAL IN FALS
-
批准号:6477163
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2000
-
负责人:JOSEPH F PODUSLO
-
依托单位:
THERAPEUTIC BENEFIT OF HYDROGEN PEROXIDE REMOVAL IN FALS
-
批准号:6625473
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2000
-
负责人:JOSEPH F PODUSLO
-
依托单位:
PROTEIN DELIVERY INTO THE CENTRAL NERVOUS SYSTEM
-
批准号:2274410
-
项目类别:
-
资助金额:$30.02万
-
财政年份:1996
-
负责人:JOSEPH F PODUSLO
-
依托单位:
PROTEIN DELIVERY INTO THE CENTRAL NERVOUS SYSTEM
-
批准号:2431303
-
项目类别:
-
资助金额:$28.96万
-
财政年份:1996
-
负责人:JOSEPH F PODUSLO
-
依托单位:
PROTEIN DELIVERY INTO THE CENTRAL NERVOUS SYSTEM
-
批准号:2714590
-
项目类别:
-
资助金额:$30.11万
-
财政年份:1996
-
负责人:JOSEPH F PODUSLO
-
依托单位:
REGULATION OF MYELINATION
-
批准号:3400941
-
项目类别:
-
资助金额:$11.31万
-
财政年份:1984
-
负责人:JOSEPH F PODUSLO
-
依托单位:
REGULATION OF MYELINATION
-
批准号:3400944
-
项目类别:
-
资助金额:$13.85万
-
财政年份:1984
-
负责人:JOSEPH F PODUSLO
-
依托单位:
REGULATION OF MYELINATION
-
批准号:3400948
-
项目类别:
-
资助金额:$11.29万
-
财政年份:1984
-
负责人:JOSEPH F PODUSLO
-
依托单位:
REGULATION OF MYELINATION
-
批准号:3400947
-
项目类别:
-
资助金额:$11.17万
-
财政年份:1984
-
负责人:JOSEPH F PODUSLO
-
依托单位:
REGULATION OF MYELINATION
-
批准号:3400945
-
项目类别:
-
资助金额:$8.69万
-
财政年份:1984
-
负责人:JOSEPH F PODUSLO
-
依托单位:
REGULATION OF MYELINATION
-
批准号:3400950
-
项目类别:
-
资助金额:$15.61万
-
财政年份:1984
-
负责人:JOSEPH F PODUSLO
-
依托单位:
REGULATION OF MYELINATION
-
批准号:3400946
-
项目类别:
-
资助金额:$8.5万
-
财政年份:1984
-
负责人:JOSEPH F PODUSLO
-
依托单位:
REGULATION OF MYELINATION
-
批准号:3400949
-
项目类别:
-
资助金额:$14.88万
-
财政年份:1984
-
负责人:JOSEPH F PODUSLO
-
依托单位:
PROTEIN GLYCATION AND DIABETIC NEUROPATHY
-
批准号:5215080
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JOSEPH F PODUSLO
-
依托单位:--
海外基金